Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Symposiums
Respiratory
7
Mins
27 Oct 2020
Dupilumab in Moderate-to-Severe Asthma: Updates from the ERS International Congress 2020
LIBERTY ASTHMA TRAVERSE,9 the first long-term study of the safety and efficacy of dupilumab in asthma, was an OLE study in patients with…
Respiratory
5
Mins
27 Oct 2020
Dupilumab Improves Outcomes for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps Irrespective of the Number of Surgeries and the Time Since Surgery or Diagnosis
Patients with serious CRSwNP or who experience disease relapse following pharmacological interventions may undergo endoscopic sinus surgery…
Nephrology
19
Mins
23 Oct 2020
Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: From Diagnosis to Outcomes
AAV encompasses a rare group of severe, progressive autoimmune diseases that involve a necrotising vasculitis and can affect many vital organs including…
Cardiology
8
Mins
20 Oct 2020
Therapeutic Advances in Patients with Heart Failure with Reduced Ejection Fraction Who Have Had a Previous Worsening Heart Failure Event
European and USA treatment guidelines are aligned in their standard recommendation of therapies for symptomatic HFrEF. First-line…
Cardiology
8
Mins
20 Oct 2020
New Insights into Icosapent Ethyl for Patients with Residual Cardiovascular Risk
REDUCE-IT was a Phase IIIb, double-blind, placebo-controlled trial that randomised 8,179 patients to receive icosapent ethyl (4 g/day) or placebo…
Cardiology
2
Mins
20 Oct 2020
First Clinical Validation of the 0-Hour/1-Hour Algorithm Using High-Sensitivity Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction in Japanese Patients
Acute myocardial infarction (AMI) is a common and life-threating condition. Approximately 10% of all emergency department (ED)…
Diabetes
6
Mins
14 Oct 2020
Kidney Disease: Improving Global Outcomes (KDIGO) New Guideline for Diabetes Management in Chronic Kidney Disease: A Meet-the-Expert Session
Diabetes is a chronic, metabolic disease characterised by elevated blood glucose levels, which over time leads to serious damage to the heart…
Hematology
12
Mins
24 Sep 2020
The Impact of Sickle Cell Disease: Updates in Therapeutics, Treatment, Management, and Future Directions
Although VOC are the hallmark of SCD, a lack of VOC events does not prevent chronic multi-organ damage. Patients with sickle cell anaemia (SCA)…
Loading posts...
« Previous
1
…
31
32
33
34
35
…
75
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View